RHEP REGIONAL HEALTH PROPERTIES, INC Insider Trading

RHEP CEO Brent Morrison purchased 20,000 shares totaling $27,650.00; stock down -69.0% from 52-week high at $1.07

Brent Morrison, CEO and President of RHEP, executed 3 separate purchases totaling 20,000 shares for $27,650.00 with a blended average price of $1.38, bringing his post-transaction holdings to 17,000 shares. The company is unprofitable (net income $-1.2M in the latest quarter) and trades at a depressed valuation relative to its 52-week range, currently at $1.07 versus a 52-week high of $3.45. His same-ticker history shows 5 prior transactions at RHEP, with the 3 completed buys showing negative 90-day returns (-11.7%, -13.1%, -2.8%), indicating a pattern of purchases that have not appreciated within the measurement window. His cross-ticker track record across 9 prior buys shows a 0.00% win rate at the 90-day mark with an average 90-day return of -23.7%, suggesting a consistent pattern of entry timing that has not resulted in near-term gains.

CEO Morrison Brent bought 6,049 shares at $1.45 across 2 transactions; stock down -57.4% from 52-week high despite +16.0% 30-day bounce.

Morrison Brent, CEO and President, made 2 separate purchases totaling 6,049 shares for $8,771.05 on December 9 and December 11, 2025, at $1.45 per share, bringing his holdings to 209,499 shares. The timing of these buys comes as the stock is significantly depressed at -57.4% from its 52-week high of $3.40, though the stock has recovered +16.0% over the prior 30 days. However, his cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate over 90 days, suggesting limited success in his prior discretionary purchasing decisions. At the company level, fundamentals present a mixed picture: the latest quarter shows $15.1M revenue with $3.4M net income and +6.8% annual revenue growth, but the company was unprofitable over its most recent full fiscal year, and the P/E ratio of 48.33 appears elevated given recent profitability challenges. This purchase warrants observation given the wide spread between his historical buying outcomes and current valuation context.

CEO Brent Morrison bought 5,403 RHEP shares at $1.41 on 2025-12-04; stock now $1.31, down -61.5% from 52-week high.

Morrison Brent, CEO and President, purchased 5,403 shares at $1.41, increasing holdings to 203,450 shares (+2.7%). The stock has since declined to $1.31, trading 61.5% below its 52-week high of $3.40, though it has recovered 4.8% over the past 30 days after a 29.6% decline over 90 days. Morrison's broader cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate, indicating a consistent pattern of purchasing before further declines. At RHEP specifically, this is his second recent transaction (following a buy on 2025-12-09 whose outcomes remain unmeasurable). The company fundamentals present mixed signals: revenue grew 6.8% year-over-year to $15.1M in the latest quarter with $3.4M net income, but full-year results were unprofitable, and the P/E of 43.67 is elevated relative to current profitability. The combination of the CEO's historically poor buy-timing pattern and the stock's severe valuation decline warrant investor scrutiny of the underlying business trajectory.

Director Burleson buys 5,000 shares of unprofitable RHEP at $1.99; stock down 47.1% from 52-week high.

Director Gene E. Burleson purchased 5,000 shares at $1.99 on 2025-08-29, establishing an initial position in Regional Health Properties. The purchase occurs as the stock has declined 47.1% from its 52-week high of $3.40 and dropped 29.4% over the prior 30 days. The company reported a net loss of $-1.4M on quarterly revenue of $10.1M and remains unprofitable on a full-year basis, despite posting 6.8% annual revenue growth. With a market cap of $4.0M, the company's small size and negative earnings profile suggest heightened operational risk that investors should evaluate alongside any interpretation of insider buying activity.

SVP O'Sullivan buys 20,000 shares at avg $1.86 over 3 days as stock trades -46.2% from 52-week high

O'Sullivan Paul Jason purchased 20,000 shares totaling $37,202.00 across 3 separate transactions (10,600 shares at $1.85, 5,600 shares at $1.92, 3,800 shares at $1.80) over August 18-20, 2025. The purchases occurred near the stock's 52-week lows relative to its range of $1.07–$3.40. However, O'Sullivan's historical track record is unfavorable: across his prior open-market activity, his average 90-day return was -39.2% with a 90d win rate of 0.00%. The timing raises concerns given the company's fundamental challenges: Regional Health Properties reported $10.1M in quarterly revenue, negative net income of $-1.4M, and unprofitable operations over its most recent full fiscal year. The purchase enlarges his holdings by 148.1% (from 13,500 to 33,500 shares), but his prior buying pattern offers no evidence of successful timing or judgment at generating positive returns.